Feed type
Facebook
Post created date
2025-08-20T15:00:19+0000
Post ID
171059586426348_1365708862225584
Over 3 million people in the U.S. live with Inappropriate Sinus Tachycardia (IST). For
those who are symptomatic and unable to tolerate medications, the HEAL-IST Trial is now enrolling.
This clinical study is evaluating the safety and effectiveness of a hybrid sinus node-sparing ablation
procedure as a potential treatment option. Learn more about the trial and patient qualifications at: HEAL- <a href="https://www.facebook.com/hashtag/ISTcom
InappropriateSinusTachycardia" target="_blank">IST.com
#InappropriateSinusTachycardia</a> <a href="https://www.facebook.com/hashtag/IST" target="_blank">#IST</a> <a href="https://www.facebook.com/hashtag/ClinicalTrial" target="_blank">#ClinicalTrial</a>
Post image URL
https://scontent-iad3-2.xx.fbcdn.net/v/t39.30808-6/535395510_1365708832225587_4433896657098677040_n.jpg?stp=dst-jpg_p720x720_tt6&_nc_cat=106&ccb=1-7&_nc_sid=127cfc&_nc_ohc=maO1JZvBmggQ7kNvwEPO6fo&_nc_oc=AdkBizAcBAle1tkW4lcwfy3mh6iPNCOVLrx9LuXN_O59j36MzS7jlQpZLTQ1NJ512BQ&_nc_zt=23&_nc_ht=scontent-iad3-2.xx&edm=AKIiGfEEAAAA&_nc_gid=vIch23wucBu38c5PUgiFQw&oh=00_AfZyVdz3_31fjduorMzzz4trPCYsiqmyuCTH2lCZG7wauQ&oe=68C276E6
Post URL
https://www.facebook.com/513124590817353/posts/1365708862225584
Post creted timestamp
